Literature DB >> 17690564

Stopping antiretroviral therapy.

Stephen Taylor1, Marta Boffito, Saye Khoo, Erasmus Smit, David Back.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17690564     DOI： 10.1097/QAD.0b013e3281c61394

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  24 in total

1.  Orogastric administration of crushed darunavir tablets for a critically ill patient.

Authors:  Catherine H Kim; Katie M Muzevich; Patricia P Fulco
Journal:  Can J Hosp Pharm       Date:  2014-01

Review 2.  Use of antineoplastic agents in patients with cancer who have HIV/AIDS.

Authors:  Michelle A Rudek; Charles Flexner; Richard F Ambinder
Journal:  Lancet Oncol       Date:  2011-05-12       Impact factor: 41.316

3.  Presence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimen.

Authors:  Stéphanie Trancart; Isabelle Charreau; Bruno Marchou; Muriel Bocquentin; Jean-Michel Molina; Jacques Izopet; Philippe Tangre; Jean-Pierre Aboulker; Anne-Marie Taburet
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

4.  Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure.

Authors:  Marita Mann; Lameck Diero; Emmanuel Kemboi; Fidelis Mambo; Mary Rono; Wilfred Injera; Allison Delong; Leeann Schreier; Kara W Kaloustian; John Sidle; Nathan Buziba; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

5.  Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Authors:  Laurelle Jackson; Jessica Hunter; Sandile Cele; Isabella Markham Ferreira; Andrew C Young; Farina Karim; Rajhmun Madansein; Kaylesh J Dullabh; Chih-Yuan Chen; Noel J Buckels; Yashica Ganga; Khadija Khan; Mikael Boulle; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

Review 6.  The same but different: autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection.

Authors:  R F Ambinder
Journal:  Bone Marrow Transplant       Date:  2009-05-18       Impact factor: 5.483

7.  Rapid and persistent selection of the K103N mutation as a majority quasispecies in a HIV1-patient exposed to efavirenz for three weeks: a case report and review of the literature.

Authors:  Ennio Polilli; Giustino Parruti; Luana Cosentino; Federica Sozio; Annalisa Saracino; Augusta Consorte; Gioacchino Angarano; Francesco Di Masi; Elena Mazzotta; Paolo Fazii
Journal:  J Med Case Rep       Date:  2009-09-18

Review 8.  Effects of political conflict-induced treatment interruptions on HIV drug resistance.

Authors:  Marita Mann; Mark N Lurie; Sylvester Kimaiyo; Rami Kantor
Journal:  AIDS Rev       Date:  2013 Jan-Mar       Impact factor: 2.500

9.  A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.

Authors:  Erica Schlesinger; Daniel Johengen; Ellen Luecke; Ginger Rothrock; Ian McGowan; Ariane van der Straten; Tejal Desai
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200

10.  Prevalence and outcomes of recycling NNRTIs despite documented NNRTI resistance in HIV-infected children and youth.

Authors:  Allison L Agwu; Jennifer Y Chang; Ryan E Wiegand; John T Wheeling; Beverly A Bohannon; Kenneth L Dominguez
Journal:  AIDS Patient Care STDS       Date:  2014-01       Impact factor: 5.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.